WALTHAM, Mass.–(BUSINESS WIRE)–Avedro, Inc. announced today that the Company’s proprietary Lasik Xtra procedure has received Canadian Approval. Lasik Xtra is a two minute procedure used in conjunction with standard Lasik to restore biomechanical integrity and strength to the cornea after a standard Lasik procedure. The procedure combines riboflavin ophthalmic solution with Avedro’s KXL™ System (UVA irradiation) to achieve accelerated corneal cross-linking during a Lasik procedure.
This procedure should provide enhanced safety for LASIK patients in Austin, Texas. This procedure will also likely allow many patients to have LASIK who were previously not eligible.
